Evidence map›Paper›PMID 40741105›Full record

ArticleWorld journal of gastroenterology2025

Clinical efficacy of surgically assisted transjugular intrahepatic portosystemic shunt for cavernous transformation of portal vein.

Yi-Fan Wu, Zhen-Dong Yue, Zhen-Hua Fan, Cheng-Bin Dong, Yu Zhang, Qi-Mei Li, Dong-Fang Liu, Guang-Zhong Xu, De-Zhong Wang, Hai-Ming Zhao and 2 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yi-Fan WuDepartment of Interventional Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Zhen-Dong YueDepartment of Interventional Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Zhen-Hua FanDepartment of Interventional Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Cheng-Bin DongDepartment of Interventional Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Yu ZhangDepartment of Interventional Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Qi-Mei LiDepartment of Interventional Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Dong-Fang LiuDepartment of Interventional Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Guang-Zhong XuCenter for Obesity and Metabolic Disease, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
De-Zhong WangCenter for Obesity and Metabolic Disease, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Hai-Ming ZhaoDepartment of Minimally Invasive Intervention, Xilin Gol League Central Hospital, Xilin Gol League 026000, Inner Mongolia Autonomous Region, China.
Zhi-Ping WuDepartment of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, Gansu Province, China.
Lei WangDepartment of Interventional Radiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China. wanglei2585@bjsjth.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransjugular intrahepatic portosystemic shunt (TIPS) is contraindicated for patients with cavernous transformation of the portal vein (CTPV) due to high surgery-related mortality risk. However, surgically assisted TIPS (SATIPS) can significantly reduce the risk.

aimTo evaluate the clinical efficacy of SATIPS, this study was conducted.

methodsOne hundred and seven patients with CTPV and esophagogastric variceal bleeding were recruited from January 2023 to December 2024.The patients were recruited from three different hospitals. Overall, 54 patients received SATIPS treatment (SATIPS group), while 53 patients did not receive SATIPS and underwent prophylactic endoscopic sclerosing ligation (control group). Subsequently, survival rates, incidence rates of gastrointestinal bleeding, incidence of hepatic encephalopathy rate, and the incidence of liver failure after treatment in both groups at 3 and 6 months were observed.

resultsThe survival rates for the SATIPS and control groups were 94.4% and 92.5% at 3 months (

conclusionFor patients with CTPV, there were no optimal treatment. Regarding long-term efficacy, SATIPS can significantly reduce the rate of rebleeding, hepatic encephalopathy and liver failure, and is associated with better survival.

Indexed as

Esophageal and Gastric VaricesGastrointestinal HemorrhageHypertension, PortalPortal VeinPortasystemic Shunt, Transjugular IntrahepaticAdultAgedFemaleHepatic EncephalopathyHumansIncidenceLiver FailureMaleMiddle AgedPostoperative ComplicationsRetrospective StudiesCavernous transformation of portal veinEsophagogastric variceal bleedingPortal hypertensionPortal vein thrombosisSurgically assisted transjugular intrahepatic portosystemic shunt

Identifiers

PMID40741105
PMCPMC12305199

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.